Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
0.356
-0.163 (-31.45%)
At close: Feb 21, 2025, 4:00 PM
0.372
+0.016 (4.49%)
After-hours: Feb 21, 2025, 7:58 PM EST
Company Description
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems.
Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Robert Hayes |
Contact Details
Address: 105 Maxess Road, Suite 124 Melville, New York 11747 United States | |
| Phone | 631 574 4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F101 |
| ISIN Number | US82003F1012 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer and Director |
| Ben Scheu | Senior Director of Sales |
| Dr. Steven Hertz M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 11, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 7, 2025 | EFFECT | Notice of Effectiveness |
| Feb 5, 2025 | SCHEDULE 13G | Filing |
| Jan 31, 2025 | SCHEDULE 13G | Filing |
| Jan 31, 2025 | AW | Amendment Withdrawal Request |
| Jan 31, 2025 | PRE 14A | Other preliminary proxy statements |
| Jan 30, 2025 | 8-K | Current Report |
| Jan 29, 2025 | POS AM | Post-Effective amendments for registration statement |
| Jan 29, 2025 | AW | Amendment Withdrawal Request |
| Jan 29, 2025 | 424B4 | Prospectus |